Water Treatment Capacity Upgrade

Illustrative case Fictional example

This fictional business case demonstrates decision analysis and approval-document design. The organization, figures, schedules, forecasts, and outcomes are illustrative; they are not evidence of work performed for a real client.

Domain
Municipal water infrastructure
Delivery approach
Predictive, with stage-gated approval
Scenario
Increase treatment capacity before forecast demand exceeds the existing plant's safe and resilient operating limit.
Decision sought
Authorize design, permitting, and procurement, with construction funding conditional on surveys, permits, and affordable tenders.
Investment scale
USD 42.0 million authorization ceiling
Planning horizon
20 years from July 2027
Primary constraints
Compliance deadline, live-plant continuity, permits, site conditions, and capital affordability.
Evidence basis
Illustrative demand forecasts, condition assumptions, concept estimates, and quantified risk allowances.
Demonstrates
Public-infrastructure option appraisal, lifecycle economics, risk allowance, and conditional capital authorization.

Document Control

Item Definition
Version 0.9 (illustrative draft)
Status Draft for conditional approval
Sponsor role Director of Municipal Infrastructure
Business owner role General Manager, Water Utility
Approving body Municipal Capital Investment Committee
Decision requested Authorize design, permitting, and procurement; approve a total project ceiling of USD 42.0 million, subject to the conditions below
Next review/decision date 15 September 2027
Planning horizon 20 years from base date
Base date 1 July 2027 (constant 2027 USD, excluding recoverable taxes)
Discount rate 4.0% real

Executive Summary

The utility must increase reliable treated-water capacity by the fictional compliance deadline of 30 June 2030. Sustainable capacity is 24 million gallons per day (MGD); the approved demand case requires 34 MGD plus defined peak and resilience performance. Without intervention, temporary bulk supply and intensive maintenance increase while deadline risk remains.

Of three options—do minimum, expand the plant, or build a new facility—expansion best balances compliance, affordability, schedule, and continuity. Conditional approval is requested for USD 42.0 million. The 20-year model gives USD 33.5 million NPV, a 1.62 benefit-cost ratio, and discounted payback in year 9. Public health and compliance are mandatory, non-monetized outcomes. Approval is conditional on surveys, permitability, and affordable tenders.

Strategic Case and Current State

The 34 MGD requirement assumes rounded annual demand growth of 1.8%, committed service extensions, and a 10% planning margin; it does not describe a real community. Filtration, pumping, residuals handling, and aging controls constrain current capacity, while peaks reduce maintenance windows.

Delay would compress design and permitting and increase temporary supply. A predominantly predictive model fits because capacity, deadline, scope, approvals, and acceptance criteria can largely be defined before construction.

Objectives and Success Measures

Objective Acceptance measure
Increase capacity Demonstrate 34 MGD average-day and 42 MGD short-duration peak output in witnessed performance testing
Maintain resilience Demonstrate at least 31 MGD with the largest new process unit unavailable
Meet quality requirements Complete a 30-day reliability run with all permit parameters met and no critical process interruption
Protect service continuity No unplanned customer outage attributable to construction; each planned shutdown approved at least 30 days ahead
Control cost and schedule Operational acceptance by 30 June 2030 and forecast final cost at or below USD 42.0 million
Enable operations Approved procedures, trained operators, spares, asset records, and maintainable controls delivered before handover

Constraints and Dependencies

The plant must remain online, with tie-ins limited to approved low-demand windows. Land, hydraulic grade, electrical supply, discharge limits, and public procurement rules constrain design. Dependencies include site and condition surveys, raw-water yield, permits, utility approval, timely decisions, equipment lead times, and commissioning operators. Demand and hydraulics require independent validation before design freeze.

Options Considered

1. Do minimum/status quo. Spend USD 10–13 million on urgent renewals, temporary treatment, and bulk-water connections. This preserves short-term service but not permanent capacity or compliance.

2. Expand the existing plant. Add modular treatment and pumping, expand residuals handling, and renew power and controls on the current site. Authorization estimate: USD 42 million.

3. Build a new facility. Construct a separate plant, intake, transmission, power, and site works. Concept range: USD 72–84 million; appraisal midpoint: USD 78 million.

Options Appraisal

Scores use a 1–5 scale, where 5 is strongest. Cost ranges include comparable concept-stage allowances.

Criterion Weight Do minimum Expand existing New facility
Capacity and compliance fit 30% 1 5 5
20-year value for money 25% 2 5 2
Delivery certainty by deadline 20% 2 4 2
Operability and resilience 15% 2 4 5
Future expansion flexibility 10% 1 3 5
Weighted score / 5 100% 1.60 4.45 3.65

Do minimum is cheapest initially but transfers risk to operations and fails the requirement. A new facility offers separation and flexibility, but excessive land, permitting, transmission, cost, and schedule exposure. Expansion has interface risk and less headroom, but reuses assets, can meet the deadline, and offers better value.

Recommended Option and Scope

Approve expansion of the existing plant.

In scope: validation surveys; design and permits; two modular treatment trains; intake and high-lift pump uprating; residuals-handling expansion; electrical, standby-power, instrumentation, and cybersecurity-compatible control upgrades; building modifications; tie-ins; testing; training; spares; records; and site restoration.

Out of scope: a new raw-water source, network growth beyond the plant boundary, unrelated office renewal, capacity above 34 MGD average-day/42 MGD peak, and routine operations staffing. Scope additions require funded change approval and may not draw reserve automatically.

Financial Case

Project authorization

Cost element USD millions
Surveys, design, permitting 4.0
Civil and process equipment 22.0
Electrical, controls, and integration 6.0
Commissioning, training, initial spares 1.5
Owner project and assurance costs 1.5
Quantified risk contingency 3.5
Expected project estimate 38.5
Sponsor-held optimism-bias reserve 3.5
Authorization ceiling 42.0

Contingency covers priced registered risks such as tie-in complexity. The governance-controlled reserve covers remaining concept uncertainty and is not duplicated in line items.

Monetized benefits and avoided costs

Item Timing Undiscounted total, constant 2027 USD millions Present value, USD millions
Avoided reactive maintenance and outage response Years 2–20, USD 1.2 million/year 22.8 15.2
Avoided temporary treatment and bulk supply Years 4–20, USD 4.8 million/year 81.6 51.9
Energy and chemical efficiency Years 4–20, USD 0.7 million/year 11.9 7.6
Avoided accelerated interim capacity project Year 8 18.0 13.2
Total benefits/avoided costs 134.3 87.8

Capital spending is assumed at USD 3.0 million, USD 10.0 million, USD 20.0 million, and USD 9.0 million in years 0–3. Incremental operating cost is USD 1.4 million annually in years 4–20: USD 23.8 million nominal and USD 15.1 million PV. Capital PV is USD 39.1 million, making total cost PV USD 54.2 million. Therefore, NPV is USD 87.8 million − USD 54.2 million = USD 33.5 million (rounding), the benefit-cost ratio is 1.62, and cumulative discounted value turns positive in year 9. No terminal value is assumed.

The incremental model avoids double counting: the year-8 project differs from recurring purchased capacity. Compliance, public health, and service equity receive no speculative dollar values.

Sensitivity Assumptions NPV, USD millions
Upside Benefits +10%; capital cost −5% 44.3
Base Assumptions above 33.5
Downside Capital +15%; benefits −20%; commissioning one year late 6.3

The downside remains economically positive but would miss the deadline; therefore, positive NPV alone is not sufficient for continuation.

Commercial and Delivery Approach

Use staged design-bid-build, early market engagement, and equipment prequalification. Complete surveys and 60% design before tender; competitively evaluate whole-life cost, compliance, schedule, supplier capacity, and interface responsibility.

Predictive delivery is tailored, not synonymous with fixing all construction in advance. Baselines govern definable work; vendor iterations, commissioning learning, and risk-based field decisions remain necessary.

Milestones

Milestone Target
Conditional approval and funding release for development September 2027
Surveys, demand validation, and concept confirmation January 2028
Permit applications and 60% design June 2028
Tender affordability gate November 2028
Contract award and design freeze February 2029
Major tie-ins complete March 2030
Performance test and operational acceptance June 2030
Benefits baseline review December 2030

Risks, Disbenefits, and Responses

Risk or disbenefit Response
Unknown buried assets or poor ground Survey before design freeze; targeted allowances; stop-work protocol
Permit conditions alter process scope Early regulator engagement; no main award until permit path is confirmed
Tender exceeds affordability Market sounding, alternate packages, value engineering; return for decision above ceiling
Live-plant tie-in disrupts service Isolation trials, rehearsed outage plans, temporary bypass, owner hold points
Long-lead equipment delays acceptance Prequalify vendors, approve early procurement only after design assurance
Construction noise, traffic, and visual impact Time restrictions, routing plan, monitoring, and community notice
Higher ongoing power and staffing demand Efficient equipment guarantees, workforce plan, and operating-budget approval
Forecast demand is lower than expected Modular commissioning and biennial demand review before optional expansion

Benefits Realization

The business owner is accountable. Finance will baseline supply, maintenance, energy, chemicals, and labor, then verify avoided costs annually against volumes and rates. Operations reports capacity and reliability monthly for one year, then quarterly. Reviews occur 6, 12, and 24 months after acceptance, with owned corrective actions.

Governance and Review Triggers

A sponsor-led steering committee approves gates, changes, contingency, and acceptance. Independent assurance occurs at concept, 60% design, tender, tie-in readiness, and acceptance. Reserve release requires risk evidence and finance concurrence.

Return to the approving authority if any of these conditions occurs:

  • Surveys invalidate reuse assumptions.
  • The permit path cannot support June 2030.
  • The recommended tender raises forecast final cost above USD 42.0 million.
  • Forecast capacity falls below acceptance criteria.
  • NPV becomes negative.
  • The acceptance date slips more than 90 days.
  • A material safety, environmental, or service-continuity risk exceeds tolerance.

Decision Required and Approval Conditions

Approve the existing-plant expansion and a maximum authorization of USD 42.0 million, with immediate release limited to USD 4.0 million for surveys, design, and permitting.

Release construction funding only when all of these conditions are met:

  • Geotechnical, structural, hydraulic, and asset-condition surveys support the scope.
  • Required permits are issued, or the approving authority confirms an acceptable, evidenced permit path.
  • Demand and raw-water assumptions are independently validated.
  • The compliant preferred tender keeps forecast final cost within USD 42.0 million and demonstrates schedule affordability.
  • Operating-budget and staffing impacts are accepted.
  • The steering committee approves the benefits baseline, risk register, execution plan, and independent assurance findings.

If any condition fails, management must revise, pause, or return with a new recommendation rather than consume reserve by default.